Dynamic Variation of RAS on Silicotic Fibrosis Pathogenesis in Rats

Abstract

The dynamic variation of renin-angiotensin system (RAS) in silicosis remains unclear. Seventy Wistar rats were divided into 7 groups including control group, silicosis groups (inhaling SiO2 for 2, 4, 8, 16 and 24 weeks, respectively) and Captopril (Cap) group. Rat lung primary fibroblasts were divided into control group, SiO₂-stimulated group (0, 0.5, 1, 3, 6, 12, 24 and 48 h) and Cap group. The silicotic nodules were formed and collagens were deposited gradually in silicosis group observed by haematoxylin and eosin (HE) staining and Van Gieson (VG) staining. Cap relieved the lung fibrosis and collagen deposition. Immunohistochemistry indicated the positive expression of α-smooth muscle actin (α-SMA) was increased gradually in silicotic rat lung tissue. Western blotting revealed the expression of collagen type I (Col I) and α-SMA was up-regulated in silicotic rat lung tissue and fibroblasts stimulated by SiO₂. Cap decreased the expression of Col I and α-SMA in silicotic rat lung tissue and fibroblasts stimulated by SiO₂. Western blotting also demonstrated the expression of angiotensin-converting enzyme (ACE) and angiotensin II type 1 receptor (AT1) was increased, and the expression of ACE2 and Mas was decreased gradually in silicotic rat lung tissue and fibroblasts stimulated by SiO₂. ELISA showed the serum levels of ACE and angiotensin II (Ang II) were also increased and ACE2 and Ang (1-7) were decreased in the silicosis group. Treatment with Cap decreased the expression levels of ACE, Ang II and AT1, and increased the expression levels of ACE2, Ang (1-7) and Mas. These findings suggested that an imbalance between ACE-Ang II-AT1 axis and ACE2-Ang (1-7)-Mas axis may participate in the development of silicosis.

Keywords

silicosis / fibroblasts / SiO₂ / renin-angiotensin system / α-smooth muscle actin

References

[1] StanburyM, RosenmanKD. Occupational health disparities: a state public health based approach. Am J Ind Med, 2014, 57(5): 596-604

[2] JiangCQ, XiaoLW, LamTH, et al.. Accelerated silicosis in workers exposed to agate dust in Guangzhou, China. Am J Ind Med, 2001, 40(1): 87-91

[3] RimalB, GreenbergAK, RomWN. Basic pathogenetic mechanisms in silicosis: current understanding. Curr Opin Pulm Med, 2005, 11(2): 169-173

[4] WangJ, ChenL, ChenB, et al.. Chronic Activation of the Renin-Angiotensin System Induces Lung Fibrosis. Sci Rep, 2015, 5: 15561

[5] MurphyAM, WongA B M. Modulation of angiotensin II signaling in the prevention of fibrosis. Fibrogenesis Tissue Repair, 2015, 8: 7

[6] ZielonkaTM, ZycinskaK C-, WynimkoJ, et al.. Angiogenic activity of sera from interstitial lung disease patients in relation to angiotensin-converting enzyme activity. Adv Exp Med Biol, 2013, 756: 213-221

[7] XuH, YangF, SunY, et al.. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis. PLoS One, 2012, 7(7): e40301

[8] Fraga-SilvaRA, FerreiraA D, SantosRA. Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension. Curr Hypertens Rep, 2013, 15(1): 31-38

[9] MengY, YuCH, LiW, et al.. Angiotensin-Converting Enzyme 2/Angiotensin- (1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway. Am J Respir Cell Mol Biol, 2014, 50(4): 723-736

[10] LiuY, XuH, GengYC, et al.. Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis. Resp Res, 2017, 18: 38

[11] HemmatiAA, NazariZ S M. A comparative study of grape seed extract and vitamin E effects on silica-induced pulmonary fibrosis in rats. Pulm Pharmacol Ther, 2008, 21(4): 668-674

[12] WangY, YangGX, ZhuZH, et al.. Effect of bone morphogenic protein-7 on the expression of epithelial-mesenchymal transition markers in silicosis model. Exp Mol Pathol, 2015, 98(3): 393-402

[13] ZhouB, LiuY, KahnM, et al.. Interactions between beta-catenin and transforming growth factor-beta signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem, 2012, 287(3): 7026-7038

[14] TumeltyKE, SmithBD, NugentMA, et al.. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor beta receptor-dependent and -independent pathways. J Biol Chem, 2014, 289(5): 2526-2536

[15] Perret-GuillaumeC, JolyL, JankowskiP, et al.. Benefits of the RAS blockade: clinical evidence before the ONTARGET study. J Hypertens Suppl, 2009, 27(2): S3-7

[16] PereiraRM, dos SantosRA, da Costa DiasFL, et al.. Renin-angiotensin system in the pathogenesis of liver fibrosis. World J Gastroenterol, 2009, 15(21): 2579-2586

[17] TharauxPL, ChatziantoniouC, FakhouriF, et al.. Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension, 2000, 36(3): 330-336

[18] YaghiniFA, SongCY, LavrentyevEN, et al.. Angiotensin II -induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation. Hypertension, 2010, 55(6): 1461-1467

[19] XieZ, SinghM S K. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts. J Cell Physiol, 2004, 198(3): 399-407

[20] SpecksU, MartinWJ2nd, RohrbachMS. Bronchoalveolar lavage fluid angiotensin-converting enzyme in interstitial lung diseases. Am Rev Respir Dis, 1990, 141(1): 117-123

[21] LiX, Molina-MolinaM, Abdul-HafezA, et al.. Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 2006, 291(5): 887-895

[22] Grönhagen-RiskaC, KurppaK, FyhrquistF, et al.. Angiotensin-converting enzyme and lysozyme in silicosis and asbestosis. Scand J Respir Dis, 1978, 59(4): 228-231

[23] NordmanH, KoskinenH, FrösethB. Increased activity of serum angiotensin-converting enzyme in progressive silicosis. Chest, 1984, 86(2): 203-207

[24] ZelkoIN, JianxinZ, RitzenthalerJD, et al.. Pulmonary hypertension and vascular remodeling in mice exposed to crystalline silica. Respir Res, 2016, 17(1): 160

[25] XiaojunW, YanL, HongX, et al.. Acetylated α-Tubulin Regulated by N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Exerts the Anti-fibrotic Effect in Rat Lung Fibrosis Induced by Silica. Sci Rep, 2016, 6: 32257

[26] UhalBD, LiX, PiaseckiCC, et al.. Angiotensin signaling in pulmonary fibrosis. Int J Biochem Cell Biol, 2012, 44(3): 465-468

[27] TipnisSR, HooperNM, HydeR, et al.. A human homolog of angiotensin-converting enzyme, cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem, 2000, 275(43): 33238-33243

[28] SantosRA, FerreiraAJ, Verano-Braga, et al.. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol, 2013, 216(2): R1-R17

[29] SimõesE, SilvaAC, TeixeiraMM. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis. Pharmacol Res, 2016, 107: 154-162

[30] ChappellM C. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?. Am J Physiol Heart Circ Physiol, 2016, 310(2): H137-H152

[31] MiyajimaA, KosakaT, KikuchiE, et al.. Renin-angiotensin system blockade: Its contribution and controversy. Int J Urol, 2015, 22(8): 721-730

[32] LiX, Molina-MolinaM A-H A. Angintensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol, 2008, 295(1): 178-185

[33] Wösten-van AsperenRM, LutterR, SpechtPA, et al.. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J Pathol, 2011, 225(4): 618-627